Effect of baseline resting heart rate on the risk of all‐cause death in Chinese patients with hypertension-Reference-Cited by-同舟云学术

Effect of baseline resting heart rate on the risk of all‐cause death in Chinese patients with hypertension

Published:2022-10-04 Issue:11 Volume:24 Page:1473-1481
ISSN:1524-6175
Container-title:The Journal of Clinical Hypertension
language:en
Short-container-title:J of Clinical Hypertension

Author:

Yulong Xia¹²^ORCID,Fangfang Fan¹²,Ya Huo³,Yaping Wei⁴,Meiqing Huang⁵,Yan Zhang¹²,Jianping Li¹²,Lishun Liu⁵⁶,Jing Zhou¹²,Yong Huo¹²^ORCID

Affiliation:

1. Department of Cardiovascular Disease Peking University First Hospital Beijing China

2. Institute of Cardiovascular Disease Peking University First Hospital Beijing China

3. State Key Laboratory of Natural Medicines Research Center of Biostatistics and Computational Pharmacy China Pharmaceutical University Nanjing China

4. Key Laboratory of Precision Nutrition and Food Quality Ministry of Education Department of Nutrition and Health College of Food Sciences and Nutritional Engineering China Agricultural University Beijing China

5. Shenzhen Evergreen Medical Institute Shenzhen China

6. Graduate School at Shenzhen Tsinghua University Shenzhen China

Funder

National Basic Research Program of China

Guangdong Science and Technology Department

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jch.14563

Reference30 articles.

1. Report on Cardiovascular Health and Diseases in China 2019: an updated summary;Chin Circ J,2020

2. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

3. 2018 ESC/ESH Guidelines for the management of arterial hypertension

4. 2020 International Society of Hypertension Global Hypertension Practice Guidelines

5. 2018 Chinese Guidelines for Prevention and Treatment of Hypertension: a report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension;J Geriatr Cardiol,2019